K. Jeff Thrasher - Concepedia

Author

K. Jeff Thrasher

Eli Lilly (United States)

Also Known As

K. J. THRASHER, K. Jeff Thrasher, K.J. Thrasher, K.Jeff Thrasher, Kenneth J. Thrasher

Publications

456

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)

About

K. Jeff Thrasher is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	229
2	Pharmacology	6	6	229
3	Biochemistry	4	4	133
4	Natural Sciences	2	2	78
5	Chemical Biology	1	1	54

K. Jeff Thrasher

Publications

425

Citations

H-Index

Page 1

	Year	Citations
Discovery and Synthesis of [6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]- 2-(4-hydroxyphenyl)]benzo[<i>b</i>]thiophene: A Novel, Highly Potent, Selective Estrogen Receptor Modulator Alan D. Palkowitz, Andrew L. Glasebrook, K. Jeff Thrasher, Journal of Medicinal Chemistry	1997	176
Quinazolinone cholecystokinin-B receptor ligands Melvin J. Yu, K. Jeff Thrasher, Jefferson R. McCowan, Journal of Medicinal Chemistry Altmetric Attention ScorePharmacotherapySystem PharmacologyPre-clinical PharmacologyTranslational Pharmacology	1991	63
Dibasic Benzo[<i>b</i>]thiophene Derivatives as a Novel Class of Active Site-Directed Thrombin Inhibitors. 1. Determination of the Serine Protease Selectivity, Structure−Activity Relationships, and Binding Orientation Daniel J. Sall, Jolie Bastian, John A. Buben, Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScorePharmacotherapyChemical BiologyPharmaceutical Chemistry	1997	54
Phenothiazines as lipid peroxidation inhibitors and cytoprotective agents Melvin J. Yu, Jefferson R. McCowan, K. Jeff Thrasher, Journal of Medicinal Chemistry BiochemistryCompetitive Scavenger ReceptorMedicineLipid PeroxidationLipid Peroxidation Inhibitors	1992	45
Discovery of <i>N</i>-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3<i>R</i>)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model Kevin R. Fales, F. George Njoroge, Harold B. Brooks, Journal of Medicinal Chemistry PharmacotherapyCancer Xenograft ModelPharmaceutical ChemistryTumor BiologyMolecular Pharmacology	2017	33
Structural Evolution and Pharmacology of a Novel Series of Triacid Angiotensin II Receptor Antagonists Alan D. Palkowitz, Mitchell I. Steinberg, K. Jeff Thrasher, Journal of Medicinal Chemistry Medicinal ChemistryNovel SeriesBiochemistryPharmacological StudyMedicine	1994	24
Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine models Harold B. Brooks, Timothy I. Meier, Sandaruwan Geeganage, Scientific Reports	2018	20
Chiral recognition of the angiotensin II (AT1) receptor by a highly potent phenoxyproline octanoamide Mitchell I. Steinberg, Alan D. Palkowitz, K. Jeff Thrasher, Bioorganic & Medicinal Chemistry Letters Angiotensin IiBiochemistryG Protein-coupled ReceptorMedicineReceptor (Biochemistry)	1994	10

Page 1